ESC Premium Access

Poster Session 6 - Epidemiology of atrial fibrillation

Event: ESC CONGRESS 2019
Topic: European Society of Cardiology
Session type: Poster Session
Date: 3 September 2019

Congress Session

20 presentations in this session

Impact of atrial fibrillation detected by implantable cardioverter-defibrillators on future stroke events in patients with heart failure

Speaker: Doctor M. Nakano (Chiba, JP)

Improvement in ejection fraction predicts heart failure after catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction : from the KPAF registry

Speaker: Doctor H. Fujimoto (Nara, JP)

Association of left atrial fibrosis extent with left ventricular geometric remodeling and diastolic dysfunction in patients with paroxysmal atrial fibrillation

Speaker: Doctor T. Gizatulina (Tyumen, RU)

Catheter ablation outcome and heart failure hospitalization in atrial fibrillation patients with preserved left ventricular ejection fraction: insights from the Kansai plus atrial fibrillation (KPAF)

Speaker: Doctor N. Tanaka (Osaka, JP)

Atrial fibrillation in arrhythmogenic right ventricular cardiomyopathy and its association with left atrial volume index

Speaker: Doctor M. Baturova (Saint Petersburg, RU)

Brain natriuretic peptide and left atrial volume predict the reduced flow velocity of left atrial appendage during sinus rhythm in patients with atrial fibrillation

Speaker: Doctor E. Fukuhara (Hyogo, JP)

Efficacy of new-generation atrial antitachycardia pacing for atrial tachyarrhythmias in patients with left ventricular dysfunction

Speaker: Doctor T. Kamakura (Suita, Osaka, JP)

Heart failure clinical phenotypes and outcomes in patients with atrial fibrillation: an analysis from the eurobservational research programme in atrial fibrillation long-term general registry

Speaker: Doctor M. Proietti (Milan, IT)

Fibrosis detected by late-gadolinium enhancement cardiac MRI is associated with atrial fibrillation and poorer ablation outcome: A meta-analysis

Speaker: Doctor T. Agbaedeng (Adelaide, AU)

Incorporation of severity of left atrial enlargement in clinical risk factors improves identification of patients at risk for development of atrial fibrillation

Speaker: Doctor D. Chawla (Milwaukee, US)

20 speakers from this session

Doctor Miyo Nakano

Chiba University Graduate School of Medicine, Chiba (Japan)
0 follower

Doctor Hajime Fujimoto

Nara Prefectural Seiwa Medical Center, Nara (Japan)
0 follower

Doctor Tatiana Gizatulina

Tyumen Cardiology Research Center, Tyumen (Russian Federation)
0 follower

Doctor Nobuaki Tanaka

Sakurabashi-Watanabe Hospital, Osaka (Japan)
0 follower

Doctor Maria Baturova

Saint-Petersburg state university, Saint Petersburg (Russian Federation)
0 follower

Doctor Eiji Fukuhara

Hyogo College of Medicine, Hyogo (Japan)
0 follower

Doctor Tsukasa Kamakura

National Cardiovascular Center, Suita, Osaka (Japan)
0 follower

Doctor Marco Proietti

University of Milan, Milan (Italy)
6 presentations
0 follower

Doctor Thomas Adam Agbaedeng

University of Adelaide, Adelaide (Australia)
0 follower

Doctor Dhruv Chawla

Aurora Sinai Aurora St. Lukes Medical Centers, Milwaukee (United States of America)
0 follower

Doctor Tunde Pal

Emergency Institute for Cardiovascular Diseases and Transplantation of Targu Mures, Targu Mures (Romania)
0 follower

Doctor In-Soo Kim

Yonsei University , Seoul (Korea (Republic of))
0 follower

Mr Jooyoung Woo

, Busan (Korea (Republic of))
0 follower

Doctor Winnie Chua

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Doctor Syuhei Ikeda

Kyoto Medical Centre, Kyoto (Japan)
0 follower

Doctor Becker Al-khayatt

East Surrey Hospital, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Associate Professor Jin Kyu Park

Hanyang university medical center, Seoul (Korea (Republic of))
0 follower

Assistant Professor Chang Hee Kwon

Konkuk University Hospital, Seoul (Korea (Republic of))
0 follower

Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)
3 presentations
0 follower

Professor Eiichi Watanabe

Fujita Health University Second Hospital, Nagoya (Japan)
0 follower

This platform is supported by

logo Novo Nordisk